PRN:CC News and Press, Profound Medical Corp.

2024-07-16 14:45:19 ET Shares of Profound Medical ( NASDAQ: PROF ) moved higher on Tuesday after Stifel upgraded the medical device company to Buy from Hold, citing a specific procedure code that Medicare proposed for the company's prostate disease therapy, TULSA. ... Read...

TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...

2024-06-14 17:17:27 ET More on Profound Medical Profound Medical gets FDA okay for TULSA AI module Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Profound Medical Financial information for Profound Medical Read ...

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...

PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...

2024-05-14 12:23:12 ET More on Profound Medical Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for ...

– Prostate segmentation using a deep learning convolutional neural network – – Model uses 24,611,072 parameters extracted from 7,466 training images – – Validated in standalone and multi-reader, multi-case clinical studies conducted by world-reno...

2024-05-11 13:47:05 ET Profound Medical Corp. (PROF) Q1 2024 Earnings Conference Call May 9, 2024, 4:30 pm ET Company Participants Stephen Kilmer - IR Arun Menawat - CEO Rashed Dewan - CFO Mathieu Burtnyk - COO Conference Call Participants John Mc...

2024-05-09 17:24:53 ET More on Profound Medical Profound Medical Corp. (PROF) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Profound Medical Historical earnings data for Profound Medical Financial information for Profound Medical ...

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, tod...